Cargando…
Safety of Antithyroid Drugs in Avoiding Hyperglycemia or Hypoglycemia in Patients With Graves’ Disease and Type 2 Diabetes Mellitus: A Literature Review
Graves’ disease (GD) may increase the difficulty of glucose control in patients with type 2 diabetes mellitus (T2DM). Therefore, selecting a drug with limited blood glucose side effects is an important issue in patients with T2DM and GD. Antithyroid drugs (ATDs) including propylthiouracil (PTU), met...
Autor principal: | Hsieh, Yu-Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372709/ https://www.ncbi.nlm.nih.gov/pubmed/37519546 http://dx.doi.org/10.7759/cureus.41017 |
Ejemplares similares
-
Antithyroid Drugs in the Management of Graves' Disease: A Friend and Foe
por: Butt, Muhammad I, et al.
Publicado: (2023) -
Antithyroid Drug-Induced Agranulocytosis: A Case Report
por: MacKay, Micaela, et al.
Publicado: (2023) -
Economic Burden of Severe Hypoglycemia Among Patients With Diabetes Mellitus
por: Ahammed, Afsar, et al.
Publicado: (2022) -
An Autobiographical Case Report on Papillary Thyroid Carcinoma with Positive Antithyroid Antibodies: Coincidence or Correlated?
por: Singh, Arkaja, et al.
Publicado: (2023) -
Paraneoplastic Hypoglycemia in Hepatocarcinoma: Case Report and Literature Review
por: Regino, Carlos A, et al.
Publicado: (2020)